Fujifilm Diosynth Biotechnologies (FDB), a biologics contract development and manufacturing organization (CDMO) with experience focused on the development and manufacture of recombinant biopharmaceuticals including proteins, advanced therapies, and monoclonal antibodies, held a ground-breaking ceremony on February 25, 2020 to signal the start of its North Carolina facility expansion project.   The 31,778 square foot addition includes the expansion of its cell culture and microbial manufacturing ...